Franziska Roth-Walter

Title: Franziska Roth-Walter: Innovator in Allergy Diagnosis and Treatment

Introduction

Franziska Roth-Walter is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of allergy diagnosis and treatment, holding a total of 3 patents. Her innovative methods and means have the potential to improve the quality of life for individuals suffering from allergies.

Latest Patents

One of her latest patents is a method for diagnosing allergies in human or animal patients. This method involves measuring the level of species-specific lipocalin, particularly lipocalin 2, in a sample from the patient. A lowered level of this lipocalin compared to that in a corresponding sample from a non-allergic individual indicates the presence of an allergy. Additionally, her patent includes a kit for performing this diagnostic method and a kit for quality control of allergen molecules or extracts used in immunotherapy. These kits determine the siderophore-iron ligand load, which is crucial for assessing the immunomodulatory potency of the allergens. Furthermore, her work provides lipocalin proteins for use in the treatment or prevention of allergies, preferably complexed with siderophore-iron ligands.

Career Highlights

Franziska has worked with notable companies such as Biomedical International R&D GmbH and Biomay Produktions- und Handels AG. Her experience in these organizations has allowed her to develop and refine her innovative approaches to allergy treatment.

Collaborations

Throughout her career, she has collaborated with esteemed colleagues, including Erika Jensen-Jarolim and Luis Fernandez Pacios. These partnerships have contributed to her success and the advancement of her research in the field of allergies.

Conclusion

Franziska Roth-Walter is a trailblazer in the realm of allergy diagnosis and treatment. Her innovative patents and collaborative efforts continue to pave the way for advancements in this critical area of healthcare.